[Elimination of urinary steroids and metopirone test following hypophysectomy for hormone-dependent cancer].
D015065:17-Hydroxycorticosteroids / Q000652:urine*; D015068:17-Ketosteroids / Q000652:urine*; D001859:Bone Neoplasms / Q000532:radiotherapy; D001943:Breast Neoplasms / Q000601:surgery; D003919:Diabetes Insipidus; D004231:Diuresis; D005260:Female; D006728:Hormones / Q000502:physiology; D006801:Humans; D007016:Hypophysectomy / Q000009:adverse effects*; D007030:Hypothalamo-Hypophyseal System / Q000503:physiopathology; D008797:Metyrapone; D009362:Neoplasm Metastasis / Q000532:radiotherapy*; D010901:Pituitary Function Tests; D010910:Pituitary Irradiation / Q000009:adverse effects*; D010913:Pituitary-Adrenal System; D011832:Radiation Injuries; D013238:Stereotaxic Techniques; D015020:Yttrium Isotopes / Q000627:therapeutic use
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D006728:Hormones; D015020:Yttrium Isotopes; D008797:Metyrapone
Elimination des stéroïdes urinaires et test à la métopirone après hypophysectomie pour cancers hormono-dépendants.